Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02972892 · ClinicalTrials.gov registry record · NA
Multi-site Anesthesia Randomized Controlled STudy of End Tidal Control Compared to Conventional Anesthesia Results
A NA study, sponsored by GE Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 248
- Enrollment target
NCT02972892 is a NA study that has completed, run by GE Healthcare. The registered enrollment target is 248 participants.
The verdict
NCT02972892, a NA study, has completed, sponsored by GE Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 248 participants
- Enrollment target
Study Summary
This is a clinical, single blind, randomized, prospective research study. The purpose of this pivotal study is to collect and analyze data on the investigational End tidal Control (Et Control) option feature. To demonstrate that End tidal Control (Et Control) performance is non-inferior to conventional anesthesia practice in an adult surgery population by comparing the performance of the Et Control Arm (investigational arm) to the Control Arm (fresh gas mode).
Interventions
- DEVICE Et Control Feature
- DEVICE Conventional Fresh Gas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 248 participants |
| Start Date | 2017-06-09 |
| Est. Completion | 2018-09-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02972892
The ClinicalTrials.gov registry entry for NCT02972892 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 248 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GE Healthcare, which has 99 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Et Control Feature is the first listed.
NCT02972892 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02972892 about?
NCT02972892 is a clinical study titled "Multi-site Anesthesia Randomized Controlled STudy of End Tidal Control Compared to Conventional Anesthesia Results". This is a clinical, single blind, randomized, prospective research study. The purpose of this pivotal study is to collect and analyze data on the investigational End tidal Control (Et Control) option feature. To demonstrate that End tidal Control (Et Control) performance is non-inferior to conventio...
What is the current status of trial NCT02972892?
This trial is currently completed. It is a NA study. The enrollment target is 248 participants. The study started on 2017-06-09. Estimated completion is 2018-09-05.
What interventions are being tested in trial NCT02972892?
The interventions under investigation include: Et Control Feature (DEVICE), Conventional Fresh Gas (DEVICE).
Who is sponsoring clinical trial NCT02972892?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.